|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 39/12 | (2006.01) |
| A61K 39/12 | (2013.01) | ||
| A61K 39/39 | (2006.01) | ||
| A61K2039/55505 | (2013.01) | ||
| C12N2770/24134 | (2013.01) | ||
| A61K 47/02 | (2013.01) | ||
| A61K2039/5252 | (2013.01) | ||
| A61K 39/104 | (2013.01) | ||
| A61K 39/39 | (2013.01) | ||
| Y02A 50/30 | (2018.01) |
| (11) | Patento numeris | 3785730 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 20184308.3 |
| Europos patento paraiškos padavimo data | 2012-12-06 | |
| (97) | Europos patento paraiškos paskelbimo data | 2021-03-03 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2024-04-24 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 11192230 | 2011-12-06 | EP | |
| PCT/EP2012/054387 | 2012-03-13 | WO |
| (72) |
Möhlen, Michael , AT
Weber, Michael , AT
Wruss, Jürgen , AT
Schlegl, Robert , AT
|
| (73) |
Valneva Austria GmbH ,
Campus Vienna Biocenter 3, 1030 Vienna,
AT
|
| (54) | ALUMINIUM COMPOUNDS FOR USE IN THERAPEUTICS AND VACCINES |
| ALUMINIUM COMPOUNDS FOR USE IN THERAPEUTICS AND VACCINES |